Pharmacist-led cardiovascular disease interventions provide highest return on investment, says NHS report

The report measured return on investment over five years of a range of interventions, including smoking cessation, cardiovascular disease and substance abuse.
Phamacy sign on exterior of community pharmacy building

Using community pharmacies to detect cardiovascular disease (CVD) in patients carries the highest return on investment of all CVD prevention interventions considered in a report by the NHS Confederation.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated